Risks and benefits of rate control versus maintenance of sinus rhythm

This publication has 20 references indexed in Scilit:

• Clinical trials update: highlights of the scientific sessions of The American College of Cardiology 2002: LIFE, DANAMI 2, MADIT‐2, MIRACLE‐ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL
  European Journal of Heart Failure, 2002
• Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion
  Journal of the American College of Cardiology, 2002
• Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ‐2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001
  European Journal of Heart Failure, 2001
• Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial
  Published by Elsevier ,2000
• Efficacy of amiodarone for the termination of persistent atrial fibrillation
  The American Journal of Cardiology, 1999
• Hemodynamic Effects of an Irregular Sequence of Ventricular Cycle Lengths During Atrial Fibrillation
  Journal of the American College of Cardiology, 1997
• Relationship Between Prothrombin Activation Fragment F1.2 and International Normalized Ratio in Patients With Atrial Fibrillation
  Stroke, 1997
• Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.
  Circulation, 1990
• RISK OF STROKE IN NON-RHEUMATIC ATRIAL FIBRILLATION
  The Lancet, 1987
• Electrocardiographic Findings Among the Adult Population of a Total Natural Community, Tecumseh, Michigan
  Circulation, 1965